Disparities in Cancer Care | Specialty

The OncLive Disparities in Cancer Care condition center page is a comprehensive resource for clinical news and expert insights on disparities in care with regards to race, gender, demographics, geographics, and socioeconomic status. This page features news articles, interviews in written and video format, and podcasts that focus on studies evaluating these various disparities and how they impact clinical trial enrollment and oncology treatment.

Dr. Olawaiye on the Social and Biological Determinants of Disparities in Women’s Cancer

March 12th 2022

Alexander B. Olawaiye, MD, discusses the social and biological determinants of disparities in women’s cancer.

ECOG-ACRIN Works to Improve Representation of Minority Populations in Cancer Clinical Trials

February 28th 2022

One of the primary goals of the ECOG-ACRIN Health Equity Committee is to continue addressing disparities that limit the representation of minority populations in cancer clinical trials.

Lack of Access to Screening Leads to More Advanced Cancer in Socially and Economically Challenged Populations

February 21st 2022

Many Americans, particularly those in communities of color or socially and economically challenged populations, are presenting with advanced-stage disease, enduring aggressive treatment, and dying from cancers that should be detected early.

Dr. Woloszynska on the Role of Community Outreach in Addressing Disparities in Prostate Cancer

February 9th 2022

Anna Woloszynska, PhD, discusses the role of community outreach in addressing disparities in prostate cancer.

Doctors Must Stand at Frontlines in Fight Against Disparities in Screening, Treatment of Thoracic Malignancies

February 8th 2022

Health care disparities remain a major issue in cancer care, and factors contributing to this inequality stretch far beyond access to clinical care.

NCCN Voices a Call to Action Against Health Care Inequity on World Cancer Day

February 8th 2022

The National Comprehensive Cancer Network is one of many organizations that is taking a stand against inequity in health care by aligning themselves with the new 3-year campaign, entitled “Close the Care Gap,” led by the Union for International Cancer Control.

Simon Shares Steps Towards Bridging Clinical Trial Disparities in Cancer

February 7th 2022

Melissa A. Simon, MD, MPH, discusses unmet needs regarding clinical trials for underserved populations with cancer, highlights the key objectives of the ECOG-ACRIN Health Equity Committee and the US Preventive Services Task Force, and shares her advice to health care professionals in the cancer space who are working to bridge some of these disparities.

Biden-Harris Administration Revives Cancer Moonshot Program

February 3rd 2022

The Biden-Harris administration has announced a plan to restart the Cancer Moonshot initiative, which President Joe Biden first launched as vice president of the Obama administration in 2016.

Equity Principles Vital for Underserved Populations in Cancer Clinical Trials

February 2nd 2022

Melissa A. Simon, MD, MPH, explains why all researchers, oncologists, and health care professionals play a role in safeguarding equity in clinical trials.

Women in Oncology: Lessons to Tell Up-and-Coming Female Oncologists

February 2nd 2022

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, provide advice to female oncologists who are just starting out their careers.

Women in Oncology: The Power of Mentorship in Overcoming Gender-Related Challenges

February 2nd 2022

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, discuss how and/or if any mentors they had during their careers helped them overcome gender-related challenges they experienced.

Women in Oncology: How Has the Culture of Oncology Practice Changed Regarding Gender Disparities?

February 2nd 2022

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

Women in Oncology: CTCA Leads Share Gender-Related Obstacles in Oncology Careers

February 2nd 2022

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, discuss some of the gender-related obstacles that they experienced throughout their careers as female oncologists.

Women in Oncology: Early Experiences as a Female Oncologist

February 1st 2022

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, discuss their early experiences as female oncologists and some of the gender-related challenges they faced during their careers.

Dr. Eakin on Racial Disparities in Uterine Cancer

January 31st 2022

Cortney Eakin, MD, discusses racial disparities and histology trends in uterine cancer.

Dr. Chandra on the Need for Resources to Evaluate Racial Disparities in Prostate Cancer

January 28th 2022

Dhyan Chandra, PhD, discusses the need for resources to evaluate racial disparities in prostate cancer.

Sorting Through Sexism, Guilt, and Motherhood in Medicine

January 27th 2022

Drs Garg, Outlaw-Evans, and Farrington discuss their experiences as women in oncology, changes they have observed in the culture of medicine, and their advice to young women entering the field.

Dr. Osarogiagbon on Geographic Disparities in Lung Cancer

January 26th 2022

Raymond U. Osarogiagbon, MD, FACP, discusses geographic disparities in lung cancer.

Gender, Racial, and Socioeconomic Status Disparities Linked With Incidence of Metastatic Bone Disease

January 26th 2022

R. Lor Randall, MD, speaks to the findings from a report that said multiple sex-related, racial/ethnic, and socioeconomic status disparities are associated with an increased incidence of metastatic bone disease originating from cancers in the prostate, renal, colon, lung, and breast.

Dr. Woloszynska on Continued Research Efforts Investigating Racial Disparities in Prostate Cancer

January 26th 2022

Anna Woloszynska, PhD, discusses continued research efforts investigating racial disparities in prostate cancer.